Sep 04, 2018 8:00am EDT SCYNEXIS, Inc. Presents Ibrexafungerp Data at the 2018 ESCMID/ASM Conference on Drug Development
Aug 09, 2018 4:15pm EDT SCYNEXIS Reports Second Quarter 2018 Financial Results and Provides Company Update
Jul 18, 2018 8:05am EDT The World Health Organization Recognizes New Antifungal Class by Granting "ibrexafungerp" to SCYNEXIS as the International Non-Proprietary Name for SCY-078
Jul 10, 2018 4:05pm EDT SCYNEXIS Reports Positive Results from Phase 2b Dose-Finding Study of Oral SCY-078 in Vulvovaginal Candidiasis
Jun 27, 2018 8:00am EDT SCYNEXIS Announces the Presentation of SCY-078 Data at the Teratology Society 58th Annual Meeting
Jun 14, 2018 8:00am EDT SCYNEXIS to Present SCY-078 Data at Three Scientific Meetings in June/July 2018
